PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportspelvic inflammatory disease
MeSH D000292 - pelvic inflammatory disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D000291:Adnexal diseases
0 Companies
0 Drugs
Success rate
D034161:Pelvic infection
26 Companies
8 Drugs
$
Success rate
D000292: 
Pelvic inflammatory disease
10 Companies
2 Drugs
$
Success rate
D004716:Endometritis
6 Companies
2 Drugs
$
Success rate
D009869:Oophoritis
0 Companies
0 Drugs
Success rate
D010249:Parametritis
0 Companies
0 Drugs
Success rate
D012488:Salpingitis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Aurobindo PharmaCefotaxime Cefotaxime  2009-11-06   
B. Braun MedicalCefotaxime Cefotaxime  2004-07-29   
Fresenius KabiCefotaxime Cefotaxime  2000-03-24   
Hikma PharmaceuticalsCefotaxime Cefotaxime  2002-11-20   
HospiraCefotaxime Cefotaxime  2006-08-11   
Lupin ResearchCefotaxime Cefotaxime  2003-09-24   
SanofiCefotaxime Claforan  1987-01-13   
Validus PharmaceuticalsCefotaxime Claforan  1982-01-01   
WockhardtCefotaxime Cefotaxime  2006-08-29   
Clinical Trials
Historical Success Rate
Phase 1
100%
3/3
Phase 2
20%
1/5
Phase 3
90%
9/10
Approved: 2Overall Success rate: 18%
All Clinical Trials
No data
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use